On the other hand, there are two studies in OSA patients focusing on potential role of circulating PSGL-1, as a driver of leucocyte infiltration facilitating the development of atherosclerosis; however, assessing PSGL-1 circulating levels provided discrepant results (50, 51). This evidence concerns the gene SELPLG and obstructive sleep apnea syndrome.